| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.69.1.107 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.RES.69.1.107 |
| P698 | PubMed publication ID | 1647274 |
| P2093 | author name string | C. G. Brilla | |
| K. T. Weber | |||
| J. S. Janicki | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| Cardiology and cardiovascular medicine | Q96320350 | ||
| diastole | Q492905 | ||
| coronary circulation | Q497232 | ||
| P304 | page(s) | 107-115 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries | |
| P478 | volume | 69 |
| Q40642989 | A growth factor for cardiac myocytes is produced by cardiac nonmyocytes |
| Q79214001 | Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension |
| Q80232499 | Aldosterone Receptor Blockers in the Treatment of Heart Failure |
| Q71265104 | Alteration of extracellular matrix in dilated cardiomyopathic hamster heart |
| Q40621879 | Antihypertensive drugs: issues beyond blood pressure control |
| Q73314370 | Antimyosin antibody imaging in experimental aortic regurgitation |
| Q36332221 | Are myocardial fibrosis and diastolic dysfunction reversible in hypertensive heart disease? |
| Q41909937 | Assessment of right ventricular fibrosis in different forms of pulmonary atresia with ventricular septal defect |
| Q24673267 | Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats |
| Q31754860 | Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil |
| Q46740756 | Beneficial cardiovascular actions of eplerenone in the spontaneously hypertensive rat. |
| Q50653136 | Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. |
| Q89885871 | CMR based measurement of aortic stiffness, epicardial fat, left ventricular myocardial strain and fibrosis in hypertensive patients |
| Q44189192 | Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction |
| Q44323041 | Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. |
| Q92728117 | Cardiac fibrosis: potential therapeutic targets |
| Q35660804 | Cardiac remodeling in systemic hypertension |
| Q44826838 | Cardiac structural and functional responses to salt loading in SHR. |
| Q46138257 | Cardioprotective effect of calcitriol on myocardial injury induced by isoproterenol in rats |
| Q40757689 | Cardioreparation and the concept of modulating cardiovascular structure and function |
| Q87791154 | Carotid atherosclerosis is associated with left ventricular diastolic function |
| Q50908555 | Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. |
| Q50659259 | Changes in the titin isoform composition in the cardiac muscle of spontaneously hypertensive rats and its restoration after a course of low-intensity red-orange irradiation. |
| Q44459151 | Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial and intrarenal arteries in spontaneously hypertensive rats |
| Q46895531 | Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. |
| Q46088350 | Decreased plasma adiponectin is associated with impaired left ventricular longitudinal systolic function in hypertensive patients: a two-dimensional speckle tracking study |
| Q36248613 | Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. |
| Q35841585 | Diastolic heart failure: recognition, diagnosis and management |
| Q93138943 | Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status |
| Q53602954 | Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats. |
| Q44389838 | Effect of Salvia miltiorrhiza on left ventricular hypertrophy and cardiac aldosterone in spontaneously hypertensive rats |
| Q44996273 | Effect of masked, white-coat, and sustained hypertension on coronary flow reserve and peripheral endothelial functions. |
| Q41259329 | Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure |
| Q58812441 | Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease |
| Q44641066 | Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats |
| Q88069559 | Effects of renal sympathetic denervation and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy. Comparison in spontaneously hypertensive rats |
| Q36344672 | Electrical and Myocardial Remodeling in Primary Aldosteronism |
| Q36948209 | Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats |
| Q37254072 | Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). |
| Q77465131 | Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats |
| Q35660795 | Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system |
| Q37786549 | From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation |
| Q40521687 | Heart failure: lessons learned over the past 25 years |
| Q35207988 | High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease |
| Q91926374 | High salt intake during puberty leads to cardiac remodelling and baroreflex impairment in lean and obese male Wistar rats |
| Q33270074 | Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice |
| Q44429121 | Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats |
| Q40387973 | Hypertension and diastolic function. |
| Q37077130 | Hypertension and microvascular remodelling |
| Q42945847 | Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemia |
| Q35821934 | Hypertensive heart disease: effects of lifestyle modifications and antihypertensive drug treatment |
| Q92243679 | Impact of a Multichannel Blocker in Attenuating Intramyocardial Artery Remodeling in Hypertensive Rats through Increased Nitric Oxide Bioavailability |
| Q47681213 | Improvements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats |
| Q37314369 | Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis |
| Q41865189 | Lack of nitric oxide- and guanosine 3':5'-cyclic monophosphate-dependent regulation of alpha-thrombin-induced calcium transient in endothelial cells of spontaneously hypertensive rat hearts. |
| Q34839964 | Left ventricular diastolic function in hypertension: methodological considerations and clinical implications |
| Q74325491 | Left ventricular diastolic function in physiologic and pathologic hypertrophy |
| Q61928874 | Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)∗∗See Appendix for the list of LIFE investigators |
| Q50677518 | Left ventricular function in hypertension: new insight by speckle tracking echocardiography. |
| Q40945928 | Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease |
| Q36736294 | Left ventricular hypertrophy of hypertensive origin: classical concepts and recent data |
| Q41375165 | Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients |
| Q41188364 | Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction |
| Q43787228 | Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats |
| Q36526896 | Macro- and micronutrients in African-Americans with heart failure |
| Q44189979 | Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat. |
| Q58238923 | Myocardial Ultrasound Tissue Characterization of Patients With Primary Aldosteronism |
| Q46813447 | Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. |
| Q72240923 | Myocardial matrix metalloproteinase(s): localization and activation |
| Q34658325 | Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application |
| Q74200346 | Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly diagnosed never-treated hypertensives |
| Q44134219 | Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds |
| Q35284582 | Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure |
| Q35579814 | Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice |
| Q46775102 | Progressive diastolic dysfunction in the female mRen(2). Lewis rat: influence of salt and ovarian hormones |
| Q44801386 | Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. |
| Q33586708 | Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives? |
| Q58816586 | Regression of pressure overload-induced left ventricular hypertrophy in mice |
| Q37632261 | Reinventing the ACE inhibitors: some old and new implications of ACE inhibition |
| Q35584082 | Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension |
| Q35017330 | Relationship between global pulse wave velocity and diastolic dysfunction in postmenopausal women |
| Q40920743 | Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. |
| Q35578965 | Renin-angiotensin system mediated mechanisms: cardioreparation and cardioprotection |
| Q79201155 | Right ventricular collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect |
| Q40380110 | Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover |
| Q27026798 | Role of estrogen in diastolic dysfunction |
| Q37325130 | Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats. |
| Q37977013 | Structural remodeling and mechanical function in heart failure |
| Q53506151 | Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. |
| Q78197580 | The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension |
| Q77418499 | The extracellular matrix in hibernating myocardium--a significant factor causing structural defects and cardiac dysfunction |
| Q34613227 | The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats. |
| Q74660329 | The pathophysiology of advanced heart failure |
| Q36304153 | The role of sodium in hypertension is more complex than simply elevating arterial pressure |
| Q80115055 | Therapeutic photobiomodulation of myocardium structure in the hypertensive SHR strain |
| Q34968274 | Traditional chinese medicine tongxinluo improves cardiac function of rats with dilated cardiomyopathy |
| Q24625500 | Transient receptor potential (TRP) channels and cardiac fibrosis |
| Q73448012 | Transmural heterogeneity of myocardial integrated backscatter in diabetic patients without overt cardiac disease |
| Q46233534 | Treatment of patients with heart failure and preserved ejection fraction |
| Q73739605 | Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function |
| Q37298352 | Wall thickness of coronary vessels varies transmurally in the LV but not the RV: implications for local stress distribution |
Search more.